0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters to the Editor |

Lack of Information in Naltrexone Study

Darius A. Rastegar, MD
Arch Gen Psychiatry. 2007;64(7):865. doi:10.1001/archpsyc.64.7.865-a.
Text Size: A A A
Published online

Extract

Comer and colleagues1 have shown that an injectable, sustained-release formulation of naltrexone can be effective for the treatment of opioid dependence in selected individuals. While these findings are promising, the impact of this treatment option will likely be limited by low rates of patient acceptance.2 Unfortunately, the authors have given us a long list of exclusion criteria but do not provide any data on the number of heroin-dependent men and women who were screened to recruit the 60 subjects in their study. Furthermore, it appears that they used a run-in period during which all subjects received naltrexone to see whether “they were willing and able to tolerate the effects of depot naltrexone”; it would be very helpful if the authors reported how many subjects dropped out during this phase of the trial. I am surprised that the Archives did not adhere to the CONSORT guidelines3 (which it endorses) in requiring the authors to provide a flow diagram showing the number of subjects assessed for eligibility and the numbers excluded.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();